These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9321515)

  • 1. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.
    Chauret N; Gauthier A; Martin J; Nicoll-Griffith DA
    Drug Metab Dispos; 1997 Oct; 25(10):1130-6. PubMed ID: 9321515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.
    Chauret N; Gauthier A; Nicoll-Griffith DA
    Drug Metab Dispos; 1998 Jan; 26(1):1-4. PubMed ID: 9443844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs.
    van Beusekom CD; Schipper L; Fink-Gremmels J
    J Vet Pharmacol Ther; 2010 Dec; 33(6):519-27. PubMed ID: 21062303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene.
    Yun CH; Shimada T; Guengerich FP
    Cancer Res; 1992 Apr; 52(7):1868-74. PubMed ID: 1551116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
    Li J; Liu Y; Zhang JW; Wei H; Yang L
    Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validated assays for human cytochrome P450 activities.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2004 Jun; 32(6):647-60. PubMed ID: 15155557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
    Sharer JE; Shipley LA; Vandenbranden MR; Binkley SN; Wrighton SA
    Drug Metab Dispos; 1995 Nov; 23(11):1231-41. PubMed ID: 8591724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human liver lauric acid hydroxylase activities.
    Castle PJ; Merdink JL; Okita JR; Wrighton SA; Okita RT
    Drug Metab Dispos; 1995 Oct; 23(10):1037-43. PubMed ID: 8654190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.
    Hickman D; Wang JP; Wang Y; Unadkat JD
    Drug Metab Dispos; 1998 Mar; 26(3):207-15. PubMed ID: 9492382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
    Newton DJ; Wang RW; Lu AY
    Drug Metab Dispos; 1995 Jan; 23(1):154-8. PubMed ID: 7720520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.
    Ono S; Hatanaka T; Hotta H; Satoh T; Gonzalez FJ; Tsutsui M
    Xenobiotica; 1996 Jul; 26(7):681-93. PubMed ID: 8819299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
    Arinç E; Bozcaarmutlu A
    J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.
    Zhao XJ; Ishizaki T
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1168-76. PubMed ID: 9399990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of substrate specificity of dog CYP1A2 using CYP1A2-deficient and wild-type dog liver microsomes.
    Mise M; Hashizume T; Komuro S
    Drug Metab Dispos; 2008 Sep; 36(9):1903-8. PubMed ID: 18573860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of indinavir in the human fetal liver microsomes.
    Chiba M; Nshime JA; Lin JH
    Drug Metab Dispos; 1997 Oct; 25(10):1219-22. PubMed ID: 9321528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA-expressed human cytochrome P450 isozymes. Inactivation by porphyrinogenic xenobiotics.
    McNamee JP; Jurima-Romet M; Kobus SM; Marks GS
    Drug Metab Dispos; 1997 Apr; 25(4):437-41. PubMed ID: 9107543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate.
    Nakajima M; Yoshida R; Shimada N; Yamazaki H; Yokoi T
    Drug Metab Dispos; 2001 Aug; 29(8):1110-3. PubMed ID: 11454729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.